Список литературы к главе 4

27. Brownlee R. Glycosylation products as toxic mediators of diabetic complications // Annu. Rev. Med. 2005. Vol. 42. P. 159–166.

28. Confidential enquiry into maternal and child health. Diabetes in pregnancy: are we providing the best care? London, CEMACH, 2007.

29. Dunne F.P., Avalos G., Durkan M., Mitchell Y., Gallacher T., Keenan M. et al. ATLANTIC DIP: pregnancy outcome for women with pregestational diabetes along the Irish Atlantic seaboard // Diabetes Care. 2009. Vol. 32, N 7. P. 1205–1206. DOI: 10.2337/dc09-1118.

30. Guerin A., Nisenbaum R., Ray J.G. Use of maternal GHb concentration to estimate the risk of congenital anomalies in the offspring of women with prepregnancy diabetes // Diabetes Care. 2007. Vol. 30, N 7. P. 1920–1925. DOI: 10.2337/dc07-0278.

31. Pearson D.W., Kernaghan D., Lee R., Penney G.C., Scottish Diabetes in Pregnancy Study Group. The relationship between pre-pregnancy care and early pregnancy loss, major congenital anomaly or perinatal death in type I diabetes mellitus // BJOG. 2007. Vol. 114, N 1. P. 104–107. DOI: 10.1111/j.1471-0528.2006.01145.x.

32. Schaefer-Graf U., Napoli A., Nolan C.J. Diabetes in pregnancy: a new decade of challenges ahead // Diabetologia. 2018. Vol. 61, N 5. P. 1012–1021. DOI: 10.1007/s00125-018-4545-y.

33. Wahabi H.A., Alzeidan R.A., Esmaeil S.A. Pre-pregnancy care for women with pre-gestational diabetes mellitus: a systematic review and meta-analysis // BMC Public Health. 2012. Vol. 12. P. 792. DOI: 10.1186/1471-2458-12-792.

34. Owens L.A., Avalos G., Kirwan B., Carmody L., Dunne F. ATLANTIC DIP: closing the loop: a change in clinical practice can improve outcomes for women with pregestational diabetes // Diabetes Care. 2012. Vol. 35. P. 1669–1671.

35. Chang A.S., Dale A.N., Moley K.H. Maternal diabetes adversely affects preovulatory oocyte maturation, development, and granulosa cell apoptosis // Endocrinology. 2005. Vol. 146, N 5. P. 2445–2453. DOI: 10.1210/en.2004-1472.

36. Fraser R.B., Waite S.L., Wood K.A., Martin K.L. Impact of hyperglycemia on early embryo development and embryopathy: in vitro experiments using a mouse model // Hum. Reprod. 2007. Vol. 22, N 12. P. 3059–3068. DOI: 10.1093/humrep/dem318.

37. Scott-Drechsel D.E., Rugonyi S., Marks D.L., Thornburg K.L., Hinds M.T. Hyperglycemia slows embryonic growth and suppresses cell cycle via cyclin D1 and p21 // Diabetes. 2013. Vol. 62, N 1. P. 234–242. DOI: 10.2337/db12-0161.

38. Szymanska M., Horosz E., Szymusik I., Bomba-Opon D., Wielgos M. Gestational diabetes in IVF and spontaneous pregnancies // Neuro Endocrinol. Lett. 2011. Vol. 32, N 6. P. 885–888.

39. Williams textbook of endocrinology / ed. by Sh. Melmed, K.S. Polonsky, P.R. Larsen, H.M. Kronenberg. Elsevier, 2015. 1920 p.

40. Coton S.J., Nazareth I., Petersen I. A cohort study of trends in the prevalence of pregestational diabetes in pregnancy recorded in UK general practice between 1995 and 2012 // BMJ Open. 2016. Vol. 6, N 1. P. e009494. DOI: 10.1136/bmjopen-2015-009494.

41. Мишарина Е.В., Боровик Н.В. Ретроспективный анализ течения беременности, наступившей в результате вспомогательных репродуктивных технологий, у пациенток с сахарным диабетом 2-го типа // Журнал акушерства и женских болезней. 2019. Т. 68, № 3. С. 25–34. DOI: 10/17816/JOWD68325-34.

42. Clinical оbesity in adults and children / ed. by P.G. Kopelman, I.D. Caterson, W.H. Dietz. Carlton: Blackwell Publishing, 2005. 493 p.

43. Khaskheli M.N., Baloch S., Baloch A.S. Infertility and weight reduction: influence and outcome // J. Coll. Physicians Surg. Pak. 2013. Vol. 23, N 10. P. 798–801.

44. International evidence-based guideline for the assessment and management of polycystic ovary syndrome 2018. URL: https://www.monash.edu/__data/assets/pdf_file/0004/1412644/PCOS_Evidence-Based-Guidelines_20181009.pdf.

45. Legro R.S., Arslanian S.A., Ehrmann D.A., Hoeger K.M., Murad M.H., Pasquali R. et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline // J. Clin. Endocrinol. Metab. 2013. Vol. 98, N 12. P. 4565–4592. DOI: 10.1210/jc.2013-2350.

46. Petersen G.L., Schmidt L., Pinborg A., Kamper-Jørgensen M. The influence of female and male body mass index on live births after assisted reproductive technology treatment: a nationwide register-based cohort study // Fertil. Steril. 2013. Vol. 99, N 6. P. 1654–1662. DOI: 10.1016/j.fertnstert.2013.01.092.

47. Supramaniam P.R., Mittal M., McVeigh E., Lim L.N. The correlation between raised body mass index and assisted reproductive treatment outcomes: a systematic review and meta-analysis of the evidence // Reprod. Health. 2018. Vol. 15, N 1. P. 34. DOI: 10.1186/s12978-018-0481-z.

48. Provost M.P., Acharya K.S., Acharya C.R., Yeh J.S., Steward R.G., Eaton J.L. et al. Pregnancy outcomes decline with increasing body mass index: analysis of 239,127 fresh autologous in vitro fertilization cycles from the 2008–2010 Society for Assisted Reproductive Technology registry // Fertil. Steril. 2016. Vol. 105, N 3. P. 663–669. DOI: 10.1016/j.fertnstert.2015.11.008.

49. American College of Obstetricians and Gynecologists. ACOG Committee opinion no. 548: weight gain during pregnancy // Obstet. Gynecol. 2013. Vol. 121, N 1. P. 210–212. DOI: 10.1097/01.aog.0000425668.87506.4c.

50. Weiss J.L., Malone F.D., Emig D., Ball R.H., Nyberg D.A., Comstock C.H. et al. Obesity, obstetric complications and cesarean delivery rate--a population-based screening study // Am. J. Obstet. Gynecol. 2004. Vol. 190, N 4. P. 1091–1097. DOI: 10.1016/j.ajog.2003.09.058.

51. American College of Obstetricians and Gynecologists. ACOG Committee opinion no. 549: obesity in pregnancy // Obstet. Gynecol. 2013. Vol. 121, N 1. P. 213–217. DOI: 10.1097/01.aog.0000425667.10377.60.

52. Хомбург Р. Стимуляция яичников: практическое руководство / пер. с англ. под ред. И.Ю. Когана. Москва: ГОЭТАР-Медиа. 2017. 288 с.

53. Chen Z.J., Shi Y., Sun Y., Zhang B., Liang X., Cao Y. et al. Fresh versus frozen embryos for infertility in the polycystic ovary syndrome // N. Engl. J. Med. 2016. Vol. 375, N 6. P. 523533. DOI: 10.1056/NEJMoa1513873.

54. Fiorentino F., Biricik A., Bono S., Spizzichino L., Cotroneo E., Cottone G. et al. Development and validation of a next-generation sequencing-based protocol for 24-chromosome aneuploidy screening of embryos // Fertil. Steril. 2014. Vol. 101, N 5. P. 1375–1382. DOI: 10.1016/j.fertnstert.2014.01.051.

55. HAPO Study Cooperative Research Group. Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics // Diabetes. 2009. Vol. 58, N 2. P. 453–459. DOI: 10.2337/db08-1112.

56. Dunne F., Brydon P., Smith K., Gee H. Pregnancy in women with Type 2 diabetes: 12 years outcome data 1990–2002 // Diabet. Med. 2003. Vol. 20, N 9. P. 734–738. DOI: 10.1046/j.1464-5491.2003.01017.x.

57. Knight K.M., Pressman E.K., Hackney D.N., Thornburg L.L. Perinatal outcomes in type 2 diabetic patients compared with non-diabetic patients matched by body mass index // J. Matern. Fetal. Neonatal. Med. 2012. Vol. 25, N 6. P. 611–615. DOI: 10.3109/14767058.2011.587059.

58. Clausen T.D., Mathiesen E., Ekbom P., Hellmuth E., Mandrup-Poulsen T., Damm P. Poor pregnancy outcome in women with Type 2 diabetes // Diabetes Care. 2005. Vol. 28, N 2. P. 323–328. DOI: 10.2337/diacare.28.2.323.

59. Owens L.A., Egan A.M., Carmody L., Dunne F. Ten years of optimizing outcomes for women with Type 1 and Type 2 diabetes in Pregnancy-the Atlantic DIP experience // J. Clin. Endocrinol. Metab. 2016. Vol. 101, N 4. P. 1598–1605. DOI: 10.1210/jc.2015-3817.

60. Murphy H.R., Steel S.A., Roland J.M., Morris D., Ball V., Campbell P.J. et al. Obstetric and perinatal outcomes in pregnancies complicated by Type 1 and Type 2 diabetes: influences of glycaemic control, obesity and social disadvantage // Diabet Med. 2011. Vol. 28, N 9. P. 1060–1067. DOI: 10.1111/j.1464-5491.2011.03333.x.

61. Metcalfe A., Sabr Y., Hutcheon J.A., Donovan L., Lyons J., Burrows J., Joseph K.S. Trends in obstetric intervention and pregnancy outcomes of canadian women with diabetes in pregnancy from 2004 to 2015 // J. Endocr. Soc. 2017. Vol. 1, N 12. P. 1540–1549. DOI: 10.1210/js.2017-00376.

62. Robker R.L., Akison L.K., Bennett B.D., Thrupp P.N., Chura L.R., Russell D.L. et al. Obese women exhibit differences in ovarian metabolites, hormones, and gene expression compared with moderate-weight women // J. Clin. Endocrinol. Metab. 2009. Vol. 94, N 5. P. 1533–1540. DOI: 10.1210/jc.2008-2648.

63. Luke B. Adverse effects of female obesity and interaction with race on reproductive potential // Fertil. Steril. 2017. Vol. 107, N 4. P. 868–877. DOI: 10.1016/j.fertnstert.2017.02.114. PMID: 28366413.

64. Crane J.M., Murphy P., Burrage L., Hutchens D. Maternal and perinatal outcomes of extreme obesity in pregnancy // J. Obstet. Gynaecol. Can. 2013. Vol. 35, N 7. P. 606–611. DOI: 10.1016/S1701-2163(15)30879-3.

65. Murphy H.R., Roland J.M., Skinner T.C., Simmons D., Gurnell E., Morrish N.J. et al. Effectiveness of a regional prepregnancy care program in women with type 1 and type 2 diabetes: benefits beyond glycemic control // Diabetes Care. 2010. Vol. 33, N 12. P. 2514–2520. DOI: 10.2337/dc10-1113.

66. Дедов И.И., Шестакова М.В., Майоров А.Ю., Викулова О.К., Галстян Г.Р. и др. Алгоритмы специализированной медицинской помощи больным сахарным диабетом // Сахарный диабет. 2019. Т. 22, № 1S. C. 42–114.

67. DE Valk H.W., van Nieuwaal N.H., Visser G.H. Pregnancy outcome in type 2 diabetes mellitus: a retrospective analysis from the Netherlands // Rev. Diabet Stud. 2006. Vol. 3, N 3. P. 134–142. DOI: 10.1900/RDS.2006.3.134.

68. Baeten J.M., Bukusi E.A., Lambe M. Pregnancy complications and outcomes among overweight and obese nulliparous women // Am. J. Public Health. 2001. Vol. 91, N 3. P. 436–440. DOI: 10.2105/ajph.91.3.436.

69. Ovesen P., Rasmussen S., Kesmodel U. Effect of prepregnancy maternal overweight and obesity on pregnancy outcome // Obstet. Gynecol. 2011. Vol. 118, N 2. Pt. 1. P. 305–312. DOI: 10.1097/AOG.0b013e3182245d49.

70. Boinpally T., Jovanovic L. Management of type 2 diabetes and gestational diabetes in pregnancy // Mt. Sinai. J. Med. 2009. Vol. 76, N 3. P. 269–280. DOI: 10.1002/msj.20115.

71. Schmidt L. Psychosocial burden of infertility and assisted reproduction // Lancet. 2006. Vol. 367, N 9508. P. 379–380. DOI: 10.1016/S0140-6736(06)68117-8.

72. Kalagiri R.R., Carder T., Choudhury S., Vora N., Ballard A.R., Govande V. et al. Inflammation in complicated pregnancy and its outcome // Am. J. Perinatol. 2016. Vol. 33, N 14. P. 1337–1356. DOI: 10.1055/s-0036-1582397.